BioTie Therapies Corp.: Notification According To Chapter 9, Section 10 Of The Finnish Securities Market Act

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 14 November 2013 at 3.30 pm.

Notification according to Chapter 9, Section 10 of the Finnish Securities Market Act

Biotie Therapies Corp. (“Company” or “Biotie”) has gained knowledge of a notification regarding changes in number of votes in accordance with Chapter 9, Section 5 of the Finnish Securities Markets Act, described below.

The notification received by the Company concerns the changes in holdings of the Company’s shares by Novo A/S as a result of the transactions carried out on 13 November 2013. As a result of these transactions, the aggregate holding of Novo A/S has decreased below 5 per cent of the total number of shares and votes of the Company.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC